NanoKnife: best clinics abroad

NanoKnife is a device used for irreversible electroporation, a form of tissue ablation. Needle electrodes deliver short electrical pulses that disrupt cell membranes and cause cell death in the targeted area. The technique mainly works through electrical effects rather than heating tissue. Its aim is local treatment; it does not treat cancer deposits throughout the body or guarantee protection of nearby organs.

Suitability depends on the tumour's site, extent, pathology and the patient's health. NanoKnife has been used for selected localised prostate cancers and studied for pancreatic and other tumours, but the evidence and clinical recommendations differ by indication. Device clearance does not establish superiority over standard cancer treatments. Assessment by a specialist team should compare established options, explain whether treatment is offered within research, and arrange follow-up. General anaesthesia, imaging guidance and monitoring are usually required, and important complications remain possible. Patients may seek an assessment abroad to discuss a research programme or focal treatment expertise; require a clear explanation of the evidence, alternatives and research safeguards for the particular cancer.

Understanding its place in cancer care

NanoKnife targets a defined area. Prostate focal treatment requires careful MRI and biopsy assessment because clinically significant cancer can exist elsewhere in the gland. Active surveillance, surgery or radiotherapy may be appropriate alternatives. European Association of Urology guidance restricts prostate ablation methods such as irreversible electroporation to well-designed prospective trials.

For pancreatic cancer, uncertainty remains about benefit compared with established care. NICE recommends use in research, and it should not automatically replace surgery or systemic treatment. General treatment information is available under oncology. Recommendations and regulatory indications must be checked for the treatment country and specific tumour.

Assessment and the procedure

The team reviews pathology, imaging, previous treatment, medicines and fitness for anaesthesia. Disclose heart rhythm problems, cardiac devices and any metal stents near the target. These can affect safety or suitability. Discuss blood thinners and preparation with clinicians without changing prescriptions independently.

Under imaging guidance, electrodes are positioned around the planned treatment zone. Electrical pulses are delivered between them, with monitoring and appropriate anaesthetic measures. Access varies by organ and can involve needles through the skin or a surgical approach. Pancreatic treatment may therefore involve a substantial operation. Prostate treatment commonly requires a temporary urinary catheter.

Risks and follow-up

Potential harms include bleeding, infection, pain, cardiac rhythm disturbance and damage to nearby structures. Prostate treatment can cause urinary retention, leakage, erectile or ejaculation changes and rarely a fistula. Pancreatic treatment can cause pancreatitis, leaks, vascular thrombosis and other serious complications. Tissue preservation is an aim, rather than a guarantee.

Follow-up checks whether cancer persists or returns and assesses function. Prostate monitoring can include PSA, MRI and further biopsies; PSA alone cannot prove successful focal treatment. Additional local or systemic treatment may be needed. Before travelling home, agree on catheter care, review appointments and contacts for complications.

Frequently asked questions

Is NanoKnife radiation treatment?

No. It uses electrical pulses delivered through electrodes, rather than ionising radiation.

Does FDA clearance mean a cure is guaranteed?

No. US clearance includes surgical ablation of soft tissue, including prostate tissue. It does not guarantee an individual's cancer outcome.

Can it replace all other cancer treatment?

No. The role depends on the organ and stage. Cancer outside the treated area requires separate consideration.

When should urgent help be sought?

Seek prompt assessment for fever, severe worsening pain, heavy bleeding, breathing difficulty or inability to pass urine after prostate treatment.